Affiliation:
1. Institute of Neurology National Clinical Research Center for Infectious Diseases the Third People's Hospital of Shenzhen Shenzhen Guangdong China
2. Medical Affairs Danaher Corporation/Cepheid New York New York USA
3. Department of Infectious Disease National Clinical Research Center for Infectious Diseases the Third People's Hospital of Shenzhen Shenzhen Guangdong China
Abstract
AbstractSince the new iLABMED was founded in June 2023, it has published three issues with 21 articles (till Dec 2023). As a journal majored in laboratory medicine, iLABMED also has to face many opportunities and challenges of laboratory medicine. This editorial summarized the main opportunities and challenges faced by iLABMED. The future prospects of laboratory medicine, which must be highlighted by iLABMED were also discussed based on a brief review of the current advances in laboratory medicine. iLABMED will continue to provide a useful platform for general‐interested, insightful, and informative articles with high quality.
Reference33 articles.
1. The important role of skin biopsies in the diagnosis of mpox
2. WHO.Prioritizing diseases for research and development in emergency contexts;2022.https://www.who.int/activities/prioritizing‐diseases‐for‐research‐and‐development‐in‐emergency‐contexts
3. Facing frailty: Are you ready?
4. WHO.WHO to identify pathogens that could cause future outbreaks and pandemics;2022.https://www.who.int/news/item/21‐11‐2022‐who‐to‐identify‐pathogens‐that‐could‐cause‐future‐outbreaks‐and‐pandemics
5. Mechanopathology of biofilm-like Mycobacterium tuberculosis cords